FDA Inspection 1249701 - Jeffrey M. Kaplan, M.D. - September 20, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Jeffrey M. Kaplan, M.D., with an inspection on September 20, 2024, issued by the Kansas City District Office, covering human drugs.

Company: Jeffrey M. Kaplan, M.D.
Inspection Date: September 20, 2024
Product Type: Human Drugs
Office: Kansas City District Office

Open in Dashboard

ID · d5bfe8a2-b8f4-4bea-b070-4708fcf5d82e

Violation Codes4

21 CFR 312.6021 CFR 312.62(b)21 CFR 50.55(e)(2)21 CFR 50.55(f)

Full citation text and observation details available on the Dashboard.